Scott McCauley

2.0k total citations
13 papers, 459 citations indexed

About

Scott McCauley is a scholar working on Oncology, Immunology and Cancer Research. According to data from OpenAlex, Scott McCauley has authored 13 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Immunology and 4 papers in Cancer Research. Recurrent topics in Scott McCauley's work include CAR-T cell therapy research (5 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). Scott McCauley is often cited by papers focused on CAR-T cell therapy research (5 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). Scott McCauley collaborates with scholars based in United States. Scott McCauley's co-authors include Victoria Smith, Carlos García, Maria Vaysberg, Héctor M. Rodrı́guez, Amanda Mikels, Min Han, Kang Zhang, Marina Kniazeva, Jennifer L. Watts and Michael Lee and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Scott McCauley

13 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott McCauley United States 8 201 192 102 97 48 13 459
Kattria van der Ploeg United States 6 353 1.8× 172 0.9× 176 1.7× 113 1.2× 34 0.7× 8 834
Donghong Ju United States 16 679 3.4× 116 0.6× 63 0.6× 112 1.2× 64 1.3× 41 846
Mark E. Drotar United Kingdom 9 401 2.0× 187 1.0× 157 1.5× 75 0.8× 56 1.2× 15 753
Yun‐Hye Jin South Korea 8 526 2.6× 174 0.9× 40 0.4× 99 1.0× 52 1.1× 9 686
Lionel Lim United States 5 423 2.1× 72 0.4× 62 0.6× 183 1.9× 28 0.6× 5 769
Rosalie Joosten Netherlands 9 279 1.4× 261 1.4× 85 0.8× 104 1.1× 90 1.9× 13 528
Gabriele Alessandrini Italy 13 255 1.3× 142 0.7× 96 0.9× 92 0.9× 27 0.6× 36 613
Maja Milanovic Germany 12 403 2.0× 124 0.6× 171 1.7× 116 1.2× 41 0.9× 21 646
Paul‐Joseph Aspuria United States 13 547 2.7× 242 1.3× 110 1.1× 197 2.0× 45 0.9× 22 808
Douglas Rouse United States 10 239 1.2× 71 0.4× 42 0.4× 34 0.4× 58 1.2× 14 433

Countries citing papers authored by Scott McCauley

Since Specialization
Citations

This map shows the geographic impact of Scott McCauley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott McCauley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott McCauley more than expected).

Fields of papers citing papers by Scott McCauley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott McCauley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott McCauley. The network helps show where Scott McCauley may publish in the future.

Co-authorship network of co-authors of Scott McCauley

This figure shows the co-authorship network connecting the top 25 collaborators of Scott McCauley. A scholar is included among the top collaborators of Scott McCauley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott McCauley. Scott McCauley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Oft, Martin, Navneet Ratti, Sandro Vivona, et al.. (2023). Abstract 1801: STK-012, an a/b-selective IL-2 activates tumor antigen specific CD25+ CD8 T cells to reject tumors without acute vascular toxicity. Cancer Research. 83(7_Supplement). 1801–1801. 1 indexed citations
2.
Aspuria, Paul‐Joseph, Sandro Vivona, Michele Bauer, et al.. (2021). An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CAR T cells and clearance of bulky lymphoma. Science Translational Medicine. 13(625). eabg7565–eabg7565. 61 indexed citations
3.
Emmerich, Jan, Michele Bauer, Bhargavi Jayaraman, et al.. (2021). Abstract 1744: STK-012, an alpha/beta selective IL-2 mutein for the activation of the antigen-activated T cells in solid tumor. Cancer Research. 81(13_Supplement). 1744–1744. 13 indexed citations
4.
Aspuria, Paul‐Joseph, Michael Bauer, Sandro Vivona, et al.. (2020). OrthoCARs: Engineered human IL-2/IL-2Rb orthogonal pairs selectively enhance CAR T cell antitumorefficacy. Blood. 136(Supplement 1). 35–35. 1 indexed citations
5.
McCauley, Scott, Rakesh Kumar Verma, & Martin Oft. (2018). Pegilodecakin, a Pegylated Human IL-10 (AM0010), Enhances the Cytotoxicity of CAR-T Cells in Vitro and In Vivo. Blood. 132(Supplement 1). 2058–2058. 4 indexed citations
6.
Ratti, Navneet, Nataliya Tovbis Shifrin, Scott McCauley, et al.. (2018). Combination of pegilodecakin and docetaxel shows synergy in tumor rejection in immune resistant TNBC model. Annals of Oncology. 29. viii421–viii421. 2 indexed citations
7.
Chan, Ivan H., Dennis Van Hoof, Brett Jorgensen, et al.. (2016). PEGylated IL-10 Activates Kupffer Cells to Control Hypercholesterolemia. PLoS ONE. 11(6). e0156229–e0156229. 7 indexed citations
8.
Chan, Ivan H., et al.. (2016). PEG-rIL-10 treatment decreases FoxP3+Tregs despite upregulation of intratumoral IDO. OncoImmunology. 5(7). e1197458–e1197458. 9 indexed citations
9.
Marshall, Derek, Susan K. Lyman, Scott McCauley, et al.. (2015). Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer. PLoS ONE. 10(5). e0127063–e0127063. 165 indexed citations
10.
Chan, Ivan H., Victoria H. Wu, Scott McCauley, Elizabeth A. Grimm, & John B. Mumm. (2015). IL-10: Expanding the Immune Oncology Horizon. PubMed. 2(4). 8 indexed citations
11.
Rodrı́guez, Héctor M., Maria Vaysberg, Amanda Mikels, et al.. (2010). Modulation of Lysyl Oxidase-like 2 Enzymatic Activity by an Allosteric Antibody Inhibitor. Journal of Biological Chemistry. 285(27). 20964–20974. 115 indexed citations
12.
13.
Mardirossian, G, et al.. (2002). Dose coverage evaluation and comparison between 2D and 3D planning for patients with breast cancer. International Journal of Radiation Oncology*Biology*Physics. 54(2). 237–237. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kattria van der Ploeg Breakdown of academic impact, for papers by Donghong Ju Breakdown of academic impact, for papers by Mark E. Drotar Breakdown of academic impact, for papers by Yun‐Hye Jin Breakdown of academic impact, for papers by Lionel Lim Breakdown of academic impact, for papers by Rosalie Joosten Breakdown of academic impact, for papers by Gabriele Alessandrini Breakdown of academic impact, for papers by Maja Milanovic Breakdown of academic impact, for papers by Paul‐Joseph Aspuria Breakdown of academic impact, for papers by Douglas Rouse
Rankless by CCL
2026